← FDA Drug Approvals (Drugs@FDA)

CLOBAZAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2020-04-24

Drug application

FDA Application #

ANDA213110

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLOBAZAM

Generic name

CLOBAZAM

Active ingredients

CLOBAZAM

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

CHARTWELL MOLECULAR

Manufacturer

Chartwell RX, LLC

First approval

2020-04-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown